S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
3 Computer Vision Stocks for Long-Term Gains From AI
Undervalued UnitedHealth Group Won’t Be For Long
Closing prices for crude oil, gold and other commodities
DocuSign and The Case for 66% Upside 
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
3 Computer Vision Stocks for Long-Term Gains From AI
Undervalued UnitedHealth Group Won’t Be For Long
Closing prices for crude oil, gold and other commodities
DocuSign and The Case for 66% Upside 
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
3 Computer Vision Stocks for Long-Term Gains From AI
Undervalued UnitedHealth Group Won’t Be For Long
Closing prices for crude oil, gold and other commodities
DocuSign and The Case for 66% Upside 
S&P 500   5,051.41
DOW   37,798.97
QQQ   431.10
Stock market today: Most of Wall Street slips as expectations rise for rates to stay high
Kinder Morgan Stock Bid Up In An Oil Breakout
ASML’s Earnings Could Bring The Stock to New Highs
3 Computer Vision Stocks for Long-Term Gains From AI
Undervalued UnitedHealth Group Won’t Be For Long
Closing prices for crude oil, gold and other commodities
DocuSign and The Case for 66% Upside 

Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$1.15
+1.8%
$1.21
$0.84
$2.03
$43.85M0.99123,240 shs101,698 shs
CZX
Canada Zinc Metals
C$0.31
+∞
C$0.31
C$0.22
C$0.39
C$51.69MN/A238,645 shs118,500 shs
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$20.86
+0.6%
C$20.86
C$18.60
C$22.79
N/AN/A468,009 shs3.04 million shs
SRZ
Stellar Resources
$0.00
$0.00
$0.00
N/AN/AN/AN/A
12 Stocks Corporate Insiders are Abandoning Cover

If a company's CEO, COO, and CFO were all selling shares of their stock, would you want to know?

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-5.83%-17.52%+1.80%+4.63%-22.60%
CZX
Canada Zinc Metals
0.00%0.00%0.00%0.00%0.00%
First Capital Realty Inc. stock logo
FCR
First Capital Realty
0.00%0.00%0.00%0.00%0.00%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
2.5143 of 5 stars
3.50.00.00.03.33.31.3
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/AN/AN/A
SRZ
Stellar Resources
N/AN/AN/AN/AN/AN/AN/AN/A

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
3.00
Buy$7.00508.70% Upside
CZX
Canada Zinc Metals
N/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/A
SRZ
Stellar Resources
N/AN/AN/AN/A

Current Analyst Ratings

Latest SRZ, BOLT, CZX, and FCR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/22/2024
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$8.00
(Data available from 4/16/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
$7.88M5.56N/AN/A$2.97 per share0.39
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/AN/A
SRZ
Stellar Resources
N/AN/AN/AN/AN/AN/A

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$69.20M-$1.83N/AN/AN/A-878.58%-51.18%-37.81%5/9/2024 (Estimated)
CZX
Canada Zinc Metals
N/AN/A0.00N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/A0.00N/AN/AN/AN/A5/1/2024 (Confirmed)
SRZ
Stellar Resources
N/AN/A0.00N/AN/AN/AN/AN/AN/A

Latest SRZ, BOLT, CZX, and FCR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/1/2024N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.29N/A-C$0.29N/AN/AN/A
3/21/2024Q4 2023
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
-$0.47-$0.47N/A-$0.47$1.97 million$2.09 million
2/6/2024Q4 2023
First Capital Realty Inc. stock logo
FCR
First Capital Realty
C$0.31C$0.81+C$0.50C$0.81N/AC$171.18 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
N/AN/AN/AN/AN/A
CZX
Canada Zinc Metals
N/AN/AN/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/AN/AN/A
SRZ
Stellar Resources
N/AN/AN/AN/AN/A

Latest SRZ, BOLT, CZX, and FCR Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
3/15/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.073/27/20243/28/20244/15/2024
2/6/2024
First Capital Realty Inc. stock logo
FCR
First Capital Realty
MonthlyC$0.072/28/20242/29/20243/15/2024
(Data available from 1/1/2013 forward)

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
0.15
5.17
5.17
CZX
Canada Zinc Metals
N/AN/AN/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/A
SRZ
Stellar Resources
N/AN/AN/A

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
86.70%
CZX
Canada Zinc Metals
N/A
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/A
SRZ
Stellar Resources
N/A

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Bolt Biotherapeutics, Inc. stock logo
BOLT
Bolt Biotherapeutics
10038.13 million27.30 millionNot Optionable
CZX
Canada Zinc Metals
147,000166.73 millionN/ANot Optionable
First Capital Realty Inc. stock logo
FCR
First Capital Realty
N/AN/AN/ANot Optionable
SRZ
Stellar Resources
N/AN/AN/ANot Optionable

SRZ, BOLT, CZX, and FCR Headlines

SourceHeadline
Stellar Blade ‘Japanese Version Special Trailer’Stellar Blade ‘Japanese Version Special Trailer’
gematsu.com - April 16 at 9:11 AM
Stellar Blade Trophies and Download Size RevealedStellar Blade Trophies and Download Size Revealed
msn.com - April 15 at 7:58 PM
Stellar Blade - Official The Journey: Behind-The-Scenes VideoStellar Blade - Official The Journey: Behind-The-Scenes Video
msn.com - April 15 at 12:18 AM
Stellar Blade: Every Feature Confirmed So FarStellar Blade: Every Feature Confirmed So Far
gamerant.com - April 14 at 7:18 PM
Stellar Blade developer diary ‘Episode 1: The Journey’Stellar Blade developer diary ‘Episode 1: The Journey’
gematsu.com - April 13 at 9:20 AM
Why Spending Lots of Time on Stellar Blades Demo Is a Double-Edged SwordWhy Spending Lots of Time on Stellar Blade's Demo Is a Double-Edged Sword
gamerant.com - April 13 at 9:20 AM
Stellar winds of three sun-like stars detected for the first timeStellar winds of three sun-like stars detected for the first time
sciencedaily.com - April 13 at 12:30 AM
Stellar Blade Demo Seems to Be Outdoing Final Fantasy 7 RebirthStellar Blade Demo Seems to Be Outdoing Final Fantasy 7 Rebirth
gamerant.com - April 12 at 7:30 PM
Stellar Blade Players Asked to Go Easy On The Demo After Reaching Major MilestoneStellar Blade Players Asked to Go Easy On The Demo After Reaching Major Milestone
gamerant.com - April 12 at 7:30 PM
The story of how Stellar Blade became a reality thanks to a taxi drivers’ strikeThe story of how Stellar Blade became a reality thanks to a taxi drivers’ strike
msn.com - April 12 at 2:29 PM
Stellar MLS extends its partnership with AI provider LundyStellar MLS extends its partnership with AI provider Lundy
housingwire.com - April 12 at 2:29 PM
How Stellar Blade Approaches Cyberpunk Differently From Other GamesHow Stellar Blade Approaches Cyberpunk Differently From Other Games
gamerant.com - April 12 at 2:29 PM
Stellar Blades Demo Is Almost Twice As Popular As Final Fantasy 7 RebirthsStellar Blade's Demo Is Almost Twice As Popular As Final Fantasy 7 Rebirth's
msn.com - April 12 at 9:29 AM
Stellar Blade Action RPG Demo Proves Wildly Popular. Devs Are Terrified by Number of Hours Players Spend With ItStellar Blade Action RPG Demo Proves Wildly Popular. Devs Are Terrified by Number of Hours Players Spend With It
gamepressure.com - April 12 at 9:29 AM
Stellar Blade Dev Is Worried Players Are Spending Too Much Time In The DemoStellar Blade Dev Is Worried Players Are Spending Too Much Time In The Demo
msn.com - April 11 at 2:27 PM
Stellar Blade release date – when does it come out on PS5?Stellar Blade release date – when does it come out on PS5?
videogamer.com - April 11 at 2:27 PM
Stellar Blade Dev Warns Players to Go Easy on the DemoStellar Blade Dev Warns Players to Go Easy on the Demo
playstationlifestyle.net - April 11 at 2:27 PM
Stellar Blade demo grinding could spoil PS5 exclusive’s launchStellar Blade demo grinding could spoil PS5 exclusive’s launch
truetrophies.com - April 11 at 9:27 AM
Stellar Blade Has Been A Souls Game This Entire TimeStellar Blade Has Been A Souls Game This Entire Time
msn.com - April 11 at 12:28 AM
Stellar Blade Has Gone GoldStellar Blade Has Gone Gold
theouterhaven.net - April 10 at 2:28 PM
Stellar Development Foundations Stellar Aid Assist Nominated for Best Use of Web3 in the 28th Annual Webby AwardsStellar Development Foundation's 'Stellar Aid Assist' Nominated for 'Best Use of Web3' in the 28th Annual Webby Awards
tmcnet.com - April 10 at 2:28 PM
Stellar Blade Has Gone Gold. Still, This Action RPG Is Set to Receive Update With Minor Fixes at LaunchStellar Blade Has Gone Gold. Still, This Action RPG Is Set to Receive Update With Minor Fixes at Launch
gamepressure.com - April 10 at 2:28 PM
Stellar Welcomes Two Seasoned Professionals to Propel Company’s SalesStellar Welcomes Two Seasoned Professionals to Propel Company’s Sales
wasteadvantagemag.com - April 9 at 11:13 PM
Stellar Blade difficulty — Story Mode confirmed for PS5 exclusiveStellar Blade difficulty — Story Mode confirmed for PS5 exclusive
truetrophies.com - April 9 at 1:12 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Bolt Biotherapeutics logo

Bolt Biotherapeutics

NASDAQ:BOLT
Bolt Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies for the treatment of cancer. The company's lead product candidate BDC-1001, which is in clinical development for the treatment of patients with human epidermal growth factor receptor 2- positive solid tumors, including breast, colorectal, endometrial, and gastroesophageal cancer. It is also developing BDC-3042, an agonist antibody targeting Dectin-2 for range of tumors, such as head and neck, non-small cell lung, ovarian, triple-negative breast, and other cancer. The company has collaboration agreements with Toray Industries, Genmab A/S, Innovent Biologics, Inc., Bristol-Myers Squibb, and F. Hoffmann-La Roche Ltd; and license agreement with Stanford University. The company was formerly known as Bolt Therapeutics, Inc. and changed its name to Bolt Biotherapeutics, Inc. in July 2015. Bolt Biotherapeutics, Inc. was incorporated in 2015 and is headquartered in Redwood City, California.

Canada Zinc Metals

CVE:CZX
Canada Zinc Metals Corp. explores for and evaluates mineral resource properties in Canada. The company primarily explores for zinc-lead-silver base metals deposits. Its flagship property is the Akie property that consists of 46 mineral claims, which cover approximately 116 square kilometers, located in the Paleozoic Selwyn Basin, British Columbia. The company was formerly known as Mantle Resources Inc. and changed its name to Canada Zinc Metals Corp. in September 2008. Canada Zinc Metals Corp. was incorporated in 1988 and is headquartered in Vancouver, Canada.
First Capital Realty logo

First Capital Realty

TSE:FCR

Stellar Resources

NYSE:SRZ
Sunrise Senior Living, Inc. (Sunrise) is a provider of senior living services in the United States, Canada and the United Kingdom. The Company offers a range of personalized senior living services, including independent living, assisted living, care for individuals with Alzheimer's and other forms of memory loss, nursing and rehabilitative care. At December 31, 2011, it operated 311 communities, including 269 communities in the United States, 15 communities in Canada and 27 communities in the United Kingdom, with a total unit capacity of approximately 30,733. In January 2013, Health Care REIT, Inc acquired Sunrise Senior Living, Inc. property portfolio. The Company also announced the sale of its management business to an entity formed by affiliates of Kohlberg Kravis Roberts & Co. L.P., affiliates of Beecken Petty O'Keefe & Company and Health Care REIT.